Author: OurCrowd

[Alpha Tau in GlobeNewswire] Alpha Tau enters into long-term lease of site in New Hampshire for second U.S. manufacturing facility

Oct 30, 2023 |

JERUSALEM, Oct. 30, 2023 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (“Alpha Tau”, or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that its U.S. subsidiary, Alpha Tau Medical Inc., has entered into a long-term lease agreement for a standalone building of over 14,000 rentable square feet in Hudson, New Hampshire, with the intention of erecting the Company’s second U.S. manufacturing site, alongside its first site in nearby Lawrence, Massachusetts. Read...

Read More

[AEYE Health in PR Newswire] AEYE Health and Topcon Screen announce partnership to enhance Point-of-Care Diabetic Retinopathy Screening with Best-in-Class AI Technology

Oct 27, 2023 |

NEW YORK, Oct. 27, 2023 /PRNewswire/ — AEYE Health, the leader in artificial intelligence-based diagnostics for retinal imaging, and Topcon Screen, a leader in point-of-care diabetic eye exams, today announced a partnership to deliver point-of-care screening for diabetic retinopathy that uses AI to produce immediate and accurate results. Read more...

Read More